-
-
-
-
-
-
-
Akari Therapeutics reports preclinical data on prostate cancer payload
-
-
-
-
-
-
-
Akari Therapeutcis (AKTX) Reports In-Line Q1 EPS
-
-
-
-
-
-
-
Akari Therapeutcis (AKTX) Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

